+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454968
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The menopause market is rapidly evolving as healthcare systems prioritize women’s health amidst shifting patient expectations and innovation in treatment paradigms. To capture new opportunities and mitigate risks, senior decision-makers must understand the critical drivers, segment dynamics, and competitive forces shaping this landscape.

Market Snapshot: Menopause Market Size, Growth, and Forecast

The menopause market grew from USD 19.97 billion in 2024 to USD 21.39 billion in 2025, reflecting resilient growth. It is projected to continue expanding at a CAGR of 7.32%, reaching USD 30.52 billion by 2030. This sustained momentum underscores strong demand, propelled by demographic shifts, therapeutic innovation, and a broader healthcare focus on patient-centered solutions.

Scope & Segmentation

This report provides comprehensive coverage of key segments, analysis of regional trends, and evaluation of the technologies influencing menopause treatments.

  • Product Type: Hormone Replacement Therapy (Combined Estrogen-Progesterone Therapy, Estrogen Therapy, Progesterone Therapy), Non-Hormonal Treatments (Antidepressants: Citalopram, Escitalopram, Fluoxetine; Botanical Supplements; Gabapentin; Pregabalin)
  • Stage of Menopause: Menopause, Perimenopause, Postmenopause
  • Route of Administration: Enteral, Parenteral, Topical
  • Distribution Channel: Hospital Pharmacies, Online Pharmacies (Company Websites, eCommerce Platforms), Retail Pharmacies
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Abbott Laboratories, Abbvie Inc., Amgen Inc., Apotex Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Cipla Ltd., Eli Lilly and Company, Ferring International Center S.A., Fervent Pharmaceuticals, LLC, Gedeon Richter PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Ipsen Group, Merck & Co.Inc., Mithra Pharmaceuticals S.A., Novartis AG, Novo Nordisk A/S, Organon & Co, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., TherapeuticsMD Inc., Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Therapeutic innovation continues to redefine menopause management, with both hormone-based and non-hormonal modalities offering greater personalization to address multi-symptom presentations.
  • Digital health platforms and telemedicine are now pivotal, increasing patient engagement, real-time treatment adjustments, and access to educational resources across all regions.
  • Regulatory frameworks are adapting to expedite the approval of emerging therapies, fostering a more competitive and diverse treatment landscape.
  • Channel strategy is evolving, with online pharmacies gaining ground for direct-to-consumer access, while traditional retail and hospital pharmacies adapt to changing patient behaviors.
  • Regional nuances—ranging from reimbursement structures in the Americas to varied regulatory constraints in EMEA and technology adoption in Asia-Pacific—demand localized strategies to maximize market responsiveness and patient reach.
  • Strategic collaborations, including between pharma companies, biotech firms, and digital health innovators, are central to accelerating development cycles and enhancing market differentiation.

Tariff Impact: Navigating U.S. Policy and Supply Chain Complexity

The 2025 United States tariff changes have influenced procurement and cost structures in menopause treatment supply chains. These measures have led manufacturers to reassess import dependencies and supplier contracts. In response, stakeholders are diversifying suppliers, investing in advanced forecasting, and exploring domestic production to sustain reliability and manage potential cost fluctuations.

Methodology & Data Sources

This report synthesizes primary research—comprising expert interviews with endocrinologists, regulatory authorities, and distribution partners—with quantitative surveys across regions. Secondary analysis incorporates peer-reviewed publications, clinical trial data, company reports, and regulatory filings. Multidimensional analytical tools were applied to ensure data credibility and actionable relevance.

SEO Focus: Menopause Market Dynamics

The menopause market continues to demonstrate strong potential for expansion as industry participants align their innovation and distribution strategies with identified growth segments and patient needs.

Why This Report Matters

  • Delivers actionable insights to inform portfolio planning, resource allocation, and partnership development across all major regions and channels.
  • Enables stakeholders to anticipate policy, regulatory, and technology shifts, reducing the risk of supply disruptions or missed opportunities.
  • Supports the design of patient-centric business models to drive sustainable, highly responsive menopause treatments in a complex global market.

Conclusion

This report equips senior leadership with strategic market intelligence needed to navigate investment, innovation, and policy planning in the rapidly changing menopause landscape. Informed decision-making and agile resource alignment will position companies to lead in this critical healthcare segment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Accelerating demand for personalized bioidentical hormone replacement therapies tailored to individual genetic profiles
5.2. Rapid growth of telehealth platforms offering virtual menopause management and counseling services
5.3. Rising adoption of plant-based nutraceutical supplements targeting vasomotor symptom relief and bone health support
5.4. Increasing investment in wearable technology for continuous monitoring of menopause-related physiological indicators
5.5. Expansion of menopause-focused digital communities and mobile apps for peer support and symptom tracking
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Menopause Market, by Product Type
8.1. Introduction
8.2. Hormone Replacement Therapy (HRT)
8.2.1. Combined Estrogen-Progesterone Therapy
8.2.2. Estrogen Therapy
8.2.3. Progesterone Therapy
8.3. Non-Hormonal Treatments
8.3.1. Antidepressants
8.3.1.1. Citalopram
8.3.1.2. Escitalopram
8.3.1.3. Fluoxetine
8.3.2. Botanical Supplements
8.3.3. Gabapentin
8.3.4. Pregabalin
9. Menopause Market, by Stage of Menopause
9.1. Introduction
9.2. Menopause
9.3. Perimenopause
9.4. Postmenopause
10. Menopause Market, by Route of Administration
10.1. Introduction
10.2. Enteral
10.3. Parenteral
10.4. Topical
11. Menopause Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Company Websites
11.3.2. eCommerce Platforms
11.4. Retail Pharmacies
12. Americas Menopause Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Menopause Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Menopause Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Abbvie Inc.
15.3.3. Amgen Inc.
15.3.4. Apotex Inc.
15.3.5. Astellas Pharma Inc.
15.3.6. AstraZeneca PLC
15.3.7. Bayer AG
15.3.8. Cipla Ltd.
15.3.9. Eli Lilly and Company
15.3.10. Ferring International Center S.A.
15.3.11. Fervent Pharmaceuticals, LLC
15.3.12. Gedeon Richter PLC
15.3.13. GlaxoSmithKline PLC
15.3.14. Glenmark Pharmaceuticals Ltd.
15.3.15. Ipsen Group
15.3.16. Merck & Co.Inc.
15.3.17. Mithra Pharmaceuticals S.A.
15.3.18. Novartis AG
15.3.19. Novo Nordisk A/S
15.3.20. Organon & Co
15.3.21. Pfizer Inc.
15.3.22. Sun Pharmaceutical Industries Ltd.
15.3.23. Teva Pharmaceutical Industries Ltd.
15.3.24. TherapeuticsMD Inc.
15.3.25. Viatris Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MENOPAUSE MARKET: RESEARCHAI
FIGURE 24. MENOPAUSE MARKET: RESEARCHSTATISTICS
FIGURE 25. MENOPAUSE MARKET: RESEARCHCONTACTS
FIGURE 26. MENOPAUSE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 110. CANADA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 111. CANADA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 112. CANADA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 113. CANADA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 114. CANADA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 115. CANADA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 116. CANADA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 117. CANADA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. CANADA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 122. CANADA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 123. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 126. MEXICO MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 127. MEXICO MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 138. MEXICO MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 142. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 143. BRAZIL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 205. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 208. GERMANY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 209. GERMANY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. GERMANY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. GERMANY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 224. FRANCE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 225. FRANCE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. FRANCE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. FRANCE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. ITALY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 256. ITALY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 257. ITALY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 258. ITALY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 259. ITALY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 260. ITALY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 261. ITALY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 262. ITALY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 263. ITALY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. ITALY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. ITALY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 272. SPAIN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 273. SPAIN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SPAIN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. SPAIN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 333. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. DENMARK MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 336. DENMARK MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2025-2030 (USD MILLION)
TABLE 337. DENMARK MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2024 (USD MILLION)
TABLE 338. DENMARK MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2025-2030 (USD MILLION)
TABLE 339. DENMARK MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 340. DENMARK MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 341. DENMARK MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2024 (USD MILLION)
TABLE 342. DENMARK MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2025-2030 (USD MILLION)
TABLE 343. DENMARK MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 344. DENMARK MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 345. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. DENMARK MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 348. DENMARK MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS MEN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Menopause market report include:
  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Ltd.
  • Eli Lilly and Company
  • Ferring International Center S.A.
  • Fervent Pharmaceuticals, LLC
  • Gedeon Richter PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Ipsen Group
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals S.A.
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 21.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 30.52 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033 - Product Image

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Menopause Market Report 2025 - Product Image

Menopause Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 135 Pages
  • Global
From
Menopause - Global Strategic Business Report - Product Image

Menopause - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Menopause Associated Vasomotor Symptoms Epidemiology Forecast 2025-2034 - Product Image

Menopause Associated Vasomotor Symptoms Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From

About the Menopause Market

The Menopause market is a subset of the Women's Health industry, focusing on the physical and emotional changes experienced by women during the transition from reproductive to non-reproductive years. It includes products and services that help women manage the symptoms of menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. It also includes treatments for conditions associated with menopause, such as osteoporosis, heart disease, and urinary incontinence. The Menopause market is a growing industry, with an increasing number of products and services available to women. Companies in the market include pharmaceutical companies, health care providers, and wellness companies. Examples include Hormone Health Network, Menopause Solutions, and Menopause Support. Additionally, there are a number of online resources and support groups available to women going through menopause. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.